📊 Score Breakdown
Offering Ability
40
Cash Runway
85
Float Risk
15
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
33%
📉 Score Deterioration
40%
• Score rose 30 points recently (worsening)
💰 Capital Raise
35%
• Low cash runway: 4 months remaining
🔄 Reverse Split
15%
• Only 4 months cash — financial pressure
💹 Market Data
Market Cap$7.95M
Shares Outstanding1.46M
Float1.45M
Cash$2.95M
Debt$232.4K
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 124.4K shares
#1
Stonepine Capital Management, LLC
48.8K shares
#2
Ikarian Capital, LLC
45.8K shares
#3
DRW Securities, LLC
15.4K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest30.6K
Days to Cover1.0
% of Float2.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
8-K
8K EVENT
May 04, 2026
13F-HR
BENEFICIAL OWNERSHIP
Mar 31, 2026
13F-HR
BENEFICIAL OWNERSHIP
Mar 31, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CNSP
📊 CNSP FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CNSP Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.